COMMUNIQUÉS West-GlobeNewswire

Philips Foundation 2024 Annual Report: expanding access to quality healthcare for 46.5 million people
05/06/2025
In 2024, Philips Foundation initiated 22 new projects and 5 new impact investments expanding its impact and reach in innovative healthcare delivery to India and South America Celebrating a decade of impact with strong [...]
MUSE Microscopy, Inc. Welcomes Dr. Derek C. Welch to Board of Directors, Appoints Him Chair of Science & Technology Committee
05/06/2025
IRVINE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc ., a pioneer in digital pathology innovation, proudly announces the appointment of Dr. Derek C. Welch , MD, FCAP, to its Board of Directors. Dr. [...]
Les animaux de compagnie les plus mignons sur la Colline du Parlement 2025 : Les gagnants sont dévoilés lors d’un gala où les vedettes portaient de riches fourrures
05/06/2025
OTTAWA, Ontario, 05 juin 2025 (GLOBE NEWSWIRE) -- La troisième cérémonie annuelle de remise des prix pour le concours « Les animaux de compagnie les plus mignons sur la Colline du Parlement » a été mémorable. Les [...]
Cutest Pets on Parliament Hill 2025: Winners Unveiled at Purr-fectly Playful Pet Gala
05/06/2025
OTTAWA, Ontario, June 05, 2025 (GLOBE NEWSWIRE) -- It was paws-itively unforgettable at the 3rd Annual Cutest Pets on Parliament Hill awards celebration, where the winning pets of 2025 were officially crowned at a [...]
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
05/06/2025
PORTLAND, Maine, June 05, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]
Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025
05/06/2025
CHATHAM, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biotechnology company with marketed products and a pipeline of development [...]
Avricore Appoints Rodger Seccombe as CEO
05/06/2025
VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ Avricore ”) is pleased to report the appointment of Rodger Seccombe as CEO of the Company. Mr. [...]
Attention Craft Beer Fans! Tilray Beverages Highlights Boldest Brews For Summer
05/06/2025
Explore Craft Beers from Atwater Brewery, Blue Point Brewing, Breckenridge Brewery, Montauk Brewing, Shock Top, SweetWater Brewing Co., Terrapin Beer Co., and Widmer Brother’s Brewing—Perfectly Crafted for the Sunny [...]
Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025
05/06/2025
WALTHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today [...]
Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis
05/06/2025
– KPL-387 Phase 2/3 trial on track to initiate in mid-2025; Phase 2 data expected in 2H 2026 – – KPL-387 Phase 1 single ascending dose data support profile for monthly dosing – – Presentation and webcast at Jefferies [...]
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
05/06/2025
TORONTO, June 05, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm"), a pharmaceutical company specialized in precision-based cannabinoids, announced the closing of the [...]
Emergent BioSolutions Supports Victoria's Voice Foundation’s National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies
05/06/2025
Continued commitment to reducing the number of opioid overdose deaths by expanding access, increasing awareness and educating the public about life-saving naloxone GAITHERSBURG, Md., June 05, 2025 (GLOBE NEWSWIRE) -- [...]
Ocugen, Inc. Announces Signing of Binding Term Sheet for the License of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
05/06/2025
Upfront fees and near-term development milestone payments totaling up to $11 million Sales milestones of $150 million or more in first 10 years of commercialization Royalties equaling 25% of net sales Ocugen to [...]
The Joint Corp. Announces $5 Million Stock Repurchase Program
05/06/2025
SCOTTSDALE, Ariz., June 05, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced that its board of directors has [...]
Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025
05/06/2025
Emerging Biomarkers in the Clinical Development of Epilepsy Medicines and OV329 Program Highlights NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated [...]
Dyne Therapeutics to Present New Preclinical Data in Facioscapulohumeral Muscular Dystrophy at the FSHD Society International Research Congress
05/06/2025
- DYNE-302 Demonstrated Functional Improvement in an FSHD Preclinical Model - WALTHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life- [...]
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia
05/06/2025
DUBLIN, June 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that LUMRYZ TM has been granted [...]
Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association®
05/06/2025
Four presentations on MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, including two clinical data presentations Additional preclinical presentations on other differentiated portfolio assets [...]
Kailera Therapeutics Appoints Adam Koppel and Christopher Hite to Board of Directors
05/06/2025
BOSTON and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of [...]

Pages